Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metobacteriosis Ear Canal Spray vs Fluconazole/Boric Acid for Fungal Otitis Externa
ChiCTR2400084252Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Metosol in otomycosis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: External ear canal secretion fungal smear negative. Planned start May 2024; status: not yet recruiting.
02
Drugs
Metosol
03
Conditions
otomycosis
Beyond the preview
Go deeper on ChiCTR2400084252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084252.